LAVA Therapeutics NV Held Extraordinary General Meeting
I'm PortAI, I can summarize articles.
LAVA Therapeutics NV held an extraordinary general meeting on November 7, 2025, where shareholders approved the appointment of Owen Hughes as executive director and Thomas Burns, Bradley Sitko, and Maricel Montano as non-executive directors. The meeting also granted discharge to board members for actions prior to the meeting and approved a resolution for a Dutch statutory merger with LAVA Therapeutics New Topco B.V., including the issuance of class A and B shares to shareholders.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments